Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1839 1
1928 1
1946 4
1947 1
1948 3
1949 5
1951 3
1952 5
1953 5
1954 1
1955 3
1956 1
1957 8
1958 2
1959 3
1960 1
1961 5
1962 4
1963 5
1964 7
1965 4
1967 4
1968 4
1969 3
1970 6
1971 5
1972 2
1973 3
1974 4
1975 5
1976 2
1977 7
1978 8
1979 15
1980 10
1981 19
1982 25
1983 18
1984 15
1985 22
1986 17
1987 33
1988 47
1989 39
1990 45
1991 43
1992 70
1993 68
1994 61
1995 81
1996 83
1997 95
1998 83
1999 101
2000 118
2001 123
2002 118
2003 117
2004 147
2005 142
2006 190
2007 171
2008 172
2009 223
2010 209
2011 225
2012 221
2013 263
2014 448
2015 585
2016 595
2017 652
2018 679
2019 671
2020 844
2021 980
2022 929
2023 964
2024 323

Text availability

Article attribute

Article type

Publication date

Search Results

9,885 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for R. human thomas
Search for R. Huban Thomas instead (2 results)
Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting.
DiNardo KW, LeBlanc TW, Chen H. DiNardo KW, et al. J Hematol Oncol. 2023 Mar 3;16(1):17. doi: 10.1186/s13045-023-01411-x. J Hematol Oncol. 2023. PMID: 36869366 Free PMC article.
Developments in investigational agents and novel regimens in acute myeloid leukemia (AML) were reported in the 2022 American Society of Hematology (ASH) annual meeting. Encouraging efficacy data were presented from first-in-human studies of two investigational menin inhibi …
Developments in investigational agents and novel regimens in acute myeloid leukemia (AML) were reported in the 2022 American Society of Hema …
Orphan quality control shapes network dynamics and gene expression.
Mark KG, Kolla S, Aguirre JD, Garshott DM, Schmitt S, Haakonsen DL, Xu C, Kater L, Kempf G, Martínez-González B, Akopian D, See SK, Thomä NH, Rapé M. Mark KG, et al. Cell. 2023 Aug 3;186(16):3460-3475.e23. doi: 10.1016/j.cell.2023.06.015. Epub 2023 Jul 20. Cell. 2023. PMID: 37478862 Free article.
The health benefits of yoga and exercise: a review of comparison studies.
Ross A, Thomas S. Ross A, et al. J Altern Complement Med. 2010 Jan;16(1):3-12. doi: 10.1089/acm.2009.0044. J Altern Complement Med. 2010. PMID: 20105062 Review.
The purpose of this article is to provide a scholarly review of the literature regarding research studies comparing the effects of yoga and exercise on a variety of health outcomes and health conditions. METHODS: Using PubMed((R)) and the key word "yoga," a comprehensive s …
The purpose of this article is to provide a scholarly review of the literature regarding research studies comparing the effects of yoga and …
Calcium Modification in Percutaneous Coronary Interventions.
Shlofmitz RA, Galougahi KK, Jeremias A, Shlofmitz E, Thomas SV, Ali ZA. Shlofmitz RA, et al. Interv Cardiol Clin. 2022 Oct;11(4):373-381. doi: 10.1016/j.iccl.2022.06.001. Epub 2022 Sep 15. Interv Cardiol Clin. 2022. PMID: 36243483 Review.
Andre-Thomas (1867-1963).
Duckett S. Duckett S. J Neurol. 2000 Mar;247(3):235-6. doi: 10.1007/s004150050574. J Neurol. 2000. PMID: 10787126 No abstract available.
Tips And Tricks for Proteome Sample Preparation.
Doucette AA. Doucette AA. J Vis Exp. 2023 Feb 3;(192). doi: 10.3791/64830. J Vis Exp. 2023. PMID: 37602878
Kovalchuk, S. I., Ziganshin, R., Shelukhina, I. Simple in-house ultra-high performance capillary column manufacturing with the FlashPack approach. ...D., Saab, F., Caron, E. Immunopeptidomics: Isolation of mouse and human MHC Class I- and II-associated peptides for …
Kovalchuk, S. I., Ziganshin, R., Shelukhina, I. Simple in-house ultra-high performance capillary column manufacturing with the FlashP …
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Kokalaki E, Ma B, Ferrari M, Grothier T, Hazelton W, Manzoor S, Costu E, Taylor J, Bulek A, Srivastava S, Gannon I, Jha R, Gealy R, Stanczuk L, Rizou T, Robson M, El-Kholy M, Baldan V, Righi M, Sillibourne J, Thomas S, Onuoha S, Cordoba S, Pule M. Kokalaki E, et al. Mol Ther. 2023 Jul 5;31(7):2089-2104. doi: 10.1016/j.ymthe.2023.03.020. Epub 2023 Mar 21. Mol Ther. 2023. PMID: 36945773 Free article.
9,885 results